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Abstract
Sero-epidemiological case control studies have observed positive relations between infections with Chlamydia pneumoniae,
Helicobacterpylon or cytomegalovirus (CMV) and the occurrence of coronary arteiy disease (CAD) and stroke Moreover, positive
relations between 'mfection bürden' and CAD and the role of mflammation have recently been descnbed However, the relations
between mfection, mflammation and the occurrence of peripheral arterial disease (PAD) have not been reported so far We
performed a multi-centre population-based case-control study, usmg serum samples of 228 young female PAD patients and 643
control women to determme IgG antibody tities and C-reactive protem The odds ratlos for PAD in women with serological
evidence for mfection with C pneumoniae, H pylon or CMV were 2 0 (95% CI, l 3-3 1), l 6 (95% CI, 11-22) and l 6 (95%, CI,
l l -2 3), respectively The cumulative number of infections was positively related to the nsk of PAD, the odds ratio was l 5 (95%
CI, l 0-2 4), 2 7 (95% CI, l 6-4 4) and 3 5 (95% CI, l 5-8 1) for women with one, two or three infections, respectively This
mcreased nsk, related to the 'mfection bürden', was found agam in the subgroup of women with a high CRP level, but not in the
subgroup with a low CRP level Infections might be a causal component in the development of PAD The nsk of PAD is not only
lelated to a smgle pathogen m particular, but also to the cumulative number of infections The positive relation between 'mfection
buiden' and PAD was only found m women with a high CRP level, which indicates that mflammation might be mvolved in the
process that leads to PAD © 2002 Eisevier Science Ireland Ltd All nghts reserved
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1. Introduction
In about half of the patients with atheroscleiosis,
conventional nsk factois cannot explam the occurience
of the disease This observaüon mdicates that addi-
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tional, äs yet undetected, nsk factors attnbute to the
development of atherosclerosis Recently, studies have
suggested that mfection with Chlamydia pneumoniae,
Helicobacter pylori 01 cytomegalovnus (CMV) might be
mdependent nsk factors fot athei othrombotic diseases
The role of these mfectious agents in the development of
CAD or stroke has frequently been studied by identify-
mg infected patients through the presence of IgG
antibodies [1] However, studies on the relation between
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C pneumomae, H pylon and CMV and penpheral
artenal disease (PAD) have not been reported so far
A mechamsm by which mfectious agents could
possibly mitiate or enhance atherogenesis is by tngger-
mg vascular mflammation Chronic mfections may
cause a low-grade mflammatory reaction, which is
leflected by the C-reactive protem (CRP) concentraüon,
that eventually causes atherogenesis [2-6] Therefore,
exploration of the relations between mfections and
atherosclerosis, m combmation with the CRP concen-
tiation, might provide msight m the pathophysiology of
atherogenesis
We exammed the relation between mfections with C
pneumomae, H pylon or CMV and penpheral artenal
disease m a population based case-control study of
young women All patients that were mcluded had at
least a 50% reduction of the lumen in at least one major
penpheral artery and had a negative history for cerebral
or coronary heart disease Subsequently, we assessed the
relation between the pathogen bürden and PAD, and we
verified the hypothesis that mfections and atherogenesis
might be Imked through mflammation
2. Methods
2 l Study design
This multi-centre, population based case-control
study was approved by the local research ethics com-
mittees of the parücipatmg hospitals (see Acknowl-
edgements)
2 2 Patients with penpheral artenal disease
Female patients were ehgible if (a) they had been
refeired to one of the collaboratmg hospitals between
Ist January 1990 and 31 st December 1999, (b) had an
angiographically confirmed diagnosis of PAD, (c) were
aged 18-49 years at the time of referral, and (d) gave
mformed consent
PAD was considered if a patient presented with
typical Symptoms of mtermittent claudication (crampmg
pam m the lower leg(s) durmg exercise) or with rest pam,
non-healmg ulcers or gangrene Intra-artenal angiogra-
phy was performed in all patients A stenotic lesion of
> 50% reduction of the lumen m at least one major
penpheral aitery (distal abdominal aorta, common ihac
artery, mternal and external ihac artery, femoral artery,
pophteal artery, anterior and posterior tibial artery,
peroneal artery) was considered diagnostic for PAD
Of the 294 ehgible PAD patients, 24 could not be
located, despite extensive efforts Of the 270 patients
who were successfully approached, 228 (78%) agreed to
participate Little more than half (132) of these patients
were referred between Januaiy 1990 and October 1995
and had participated m an eaiher peifoimed multi-
centre population-based case-control study in which the
relations between the use of oral contraceptives and
PAD were mvestigated by means of a questionnaire
This case-control study consisted of three sub-studies,
beside patients with PAD, the two other case gioups
mcluded were stroke patients and patients with a
myocardial infarction (MI) [7-9] In the group of
women with PAD, those who also had a history of MI
or stroke were excluded because havmg a history of MI
or cerebral ischemia could have affected the decision to
descnbe oral contraceptives In addition, one large
control group of women was mcluded to which each
group of patients was contrasted
2 3 Controls
The population-based control group of women was
recruited by random digit diallmg (RDD), random
phone numbers (m a certam area) were dialled and
households were ascertamed for ehgible individuals
(female, aged 18-49 years) who were subsequently
asked to participate [10,11] This method resulted in
the selection of controls who were approximately (5-year
strata) the same age äs the patients and who hved in the
Service areas of the parücipatmg hospitals In 1996, 1259
ehgible women were reached by RDD, of whom 925
were mcluded m the case control studies that mvesti-
gated the relation between the use of oral contraceptives
and MI, PAD or stroke [7-9] For the present analysis,
905 of these 925 women controls were approached
agam In total, 262 could not be leached or refused to
participate agam for a vanety of reasons, e g fear for
venepuncture or lack of time The remammg 643 women
(71%) were mcluded m this analysis
2 4 Data collection
Between Ist June 1998 and Ist May 2000, all
participants had their blood pressure measured, donated
non-fastmg venous blood samples and handed m a
structuied questionnaire Blood pressure was measured
semi-automatically by a physician (OmronM/ OM-
RON Healthcare GmbH, Hamburg, Germany) at one
pomt in time Serum or plasma were stored at —80 °C
until processed Serum total cholesterol, tnglycende and
glucose concentration were measured on a chnical
analyser (Röche/Hitachi® 747) The HDL-cholesterol
deteimmation was performed on a different analyser
(Röche/Hitachi® 911) The plasma CRP concentration
was determmed by a commercial EIA with a sensitivity
of 0 2 mg/1 (CRP EAI HS, Kordia, The Netherlands)
Plasma CRP concentrations of 10 mg/1 and above were
classified äs > 10 mg/1
Data obtamed from the questionnaire mcluded cui-
rent medication use and classical risk factors (body mass
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index (BMI), smokmg, history of hypercholesterolemia,
history of diabetes, histoiy of hypertension and family
history of caidiovascular disease) We categonsed
smokers äs curient, former or never A positive history
of hypercholesterolemia was defined by the use of
cholesterol lowermg medication or a serum total cho-
lesterol > 5 0 mmol/1 A positive history of diabetes was
defmed by the use of glucose lowenng medication or a
(non-fastmg) serum glucose > 11 0 mmol/1
A positive history of hypertension was defined by the
use of antihypertensiva or a systohc blood pressure >
160 mmHg or a diastohc blood piessure >95 mmHg
The socio-economic Status was defined äs the highest
level of education attended by the participant pnmaiy
school, secondary school or higher education/umversity
2 5 Determination oflgG antibodies to mfectwus agents
Immunoglobulm G antibodies to C pneumomae were
determmed by a vahdated m-house enzyme immuno-
assay (EIA) [12-14] Bnefly, C pneumomae (stiam TW-
183) was piopagated in six-well microtitre plates
Elementary bodies were punfied by centnfugation
through a layei of 35% sodium diatnzoate and used to
coat microtitre plates Antibodies to the chlamydial LPS
weie intentionally mcluded, smce they show the stron-
gest association with cardiovasculai disease All subjects
were categonsed mto three groups according to their
IgG titie negative, positive and l <6400, and positive
and l > 6400 For the final analysis, the first two
groups weie pooled together This cut-off titre was
pieviously shown to be associated with cardiovascular
nsk [15] Under the conditions descnbed, this cut-off
titre is approximately equivalent to an antibody titre of
1 64 in the micro-immunofluorescence test (MIF)
IgG antibodies to H pylon and cytomegalovirus weie
determmed by the use of commercial EIA Positivity was
defined according to the instructions of the manufac-
tuier (Enzygnost® Anti-Hehcobacter pylon II/IgG and
Enzygnost® Anti-CMV/IgG, Dade Behrmg) All assays
weie performed by a smgle technician who was unaware
of the ongm of the samples (case 01 control)
2 6 Statistical analysis
The assumptions foi the power calculation were the
following (1) the prevalence of C pneumomae, H pylon
or CMV seropositivity would be « 50% m a population
of this age, (2) the lelative nsk of PAD m peisons with
high level IgG antibodies compaied with those without
would be 2, (3) 150 PAD patients and 300 control
women would be mcluded, and (4) α 5Ξ 0 05 would be
accepted Then, a 2-fold increase m the nsk of PAD
would be detected with power 0 88
Mean or median values or proportions for cardiovas-
cular nsk factors were calculated for patients and
control women separately The peicentage of PAD
patients seropositive for C pneumomae H pylon or
CMV was compared to the percentage of controls
havmg a positive titre agamst the same mfectious agent
The ciude and adjusted odds ratlos, äs estimates for the
relative nsk of PAD m women with a positive titre
compared to women with a negative titre, were calcu-
lated usmg unconditional logistic regression Adjust-
ment was made for the following potentially
confoundmg factors age, smokmg and educational level
(low, middle or high)
The number of mfections was deteimmed for each
participant The crude and the adjusted odds ratios for
PAD were calculated m women with one, two or three
mfections compared to women without any mfection
The median CRP levels m women with none, one, two
or three mfections weie calculated for PAD patients and
healthy women separately The Kruskal-Walhs test was
used to study the differences between the median CRP
levels
Plasma CRP concentration was dichotomised with
the overall median value (l 94 mg/1) äs cut-off pomt To
evaluate whether the pathogen bürden and CRP level
jointly affect the risk of PAD, we performed logistic
regression analysis on two subgroups of women, one for
all women with CRP at or below its median value and
one for those above this value The following potentially
confoundmg factors were mcluded in the logistic regres-
sion models age, smokmg, educational level (low,
middle or high), BMI, histoiy of hypercholesterolemia
(yes, no), history of diabetes mellitus (yes, no) and
histoiy of hypertension (yes, no)
3. Results
Table l shows the charactenstics of the 228 PAD
patients and 643 control women Traditional risk factois
for atheroscleiosis were moie pievalent m the group of
patients compared to the control group of women The
median plasma CRP concentration was higher in the
PAD patients compared to the controls
Table 2 shows that high positive titres agamst C
pneumomae were found m 23% of the PAD patients
compared to 13% of the control women, the prevalence
of detectable IgG antibodies was much higher, namely
81 and 82% m the PAD patients and control women,
respectively Some 40% of the patients were seropositive
for H pylon compared to 26% of the controls and CMV
seropositivity was found m 71% of the patients and 56%
of the controls
The odds ratios and the 95% confidence mtervals (CI)
for PAD m women with a positive titre compared to
women without are shown m Table 3 The crude odds
latio was l 9 (95% CI, 13-28) foi C pneumomae l 9
(95% CI, l 4-2 6) for H pylon and l 9 (95% CI, l 4-
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Tdble l
Chdractenstics of PAD patients and control women
Age in years (medn,
S D )
BMI m kg/m2 (mean,
S D )
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141 3 + 232
846±12 l
653 + 438
5 63 + l 34
l 29 + 039
208±1 10
3 41 ± l 36
495 + 293
391 (l 6-100)
129 4+ 19 3
821 + 114
4 13 + 1 39
536+109
l 41+035
l 50 + 093
328 + 096
412 + 235
l 40 (0 5-5 1)
* Positive history of hypercholesterolemia was defined äs the use of
lipid lowermg medication and/or cholesterol plasma concentration
2 5 0 mmol/1
f Positive history of diabetes was defined äs the use of blood glucose
lowermg medication and/or (non-fastmg) glucose plasma concentra-
tion 2110 mmol/1
1 Positive history of hypertension was defined äs the use of anti-
hypertensiva and/or systohc BP 2 160 mmHg and/or diastohc BP 2 90
mmHg
2 6) for CMV. After adjustment for potential confoun-
ders, the odds ratio was 2.0 (95% CI; 1.3-3.1) for C
pneumoniae, l 6 (95% CI; 1.1-2.2) for H pylori and 1.6
(95% CI; 1.1-2.3) for CMV. Attenuations of the odds
ratios were mainly caused by adjustment for age.
The adjusted odds ratio for PAD mcreased with the
cumulative number of infections and was l 5 (95% CI,












* A positive C pneumoniae IgG titre is defined by an m-house
enzyme-lmked immunosorbent dssay (ELISA) with cut-off title chosen
at l 6400
^ A positive H pylori IgG titre was defined by a commercidl ELISA
dssay (Enzygnost®Anti-// pylori II/IgG, Ddde Behnng)
* A positive CMV IgG titre was defined by a commercial ELISA
assay (Enzygnost® Anli-CMV/IgG, Ddde Behrmg)
Table 3
Crude and adjusted odds ratios (95% CI) for C pneumoniae, H pylori









1 9 (1 3-28)
1 9 (1 3-2 9)
2 0 ( 1 3-30)
2 0 ( 1 3-3 1)
H pylori
1 9 (1 4-2 6)




1 9 (1 4-26)
1 7 (1 2-2 4)
1 7 (1 2-2 5)
1 6(1 1-23)
8.1) for women with one, two or three infections,
respectively (Table 4). No positive relation between the
number of infections and the CRP level was found. In
healthy individuals with zero, one, two or three infec-
tions the median CRP levels were 1.6, 1.3, 1.3 and 1.5
mg/1, respectively (Kruskal-Wallis test, P = 0.69) and in
PAD patients the median CRP levels were 4 3, 3.8, 3.6
and 7.6 mg/1, respectively (Kruskal-Wallis test, P =
0.16)
Analyses of subgroups according to CRP level
showed that, among women with a high CRP level,
the odds ratio for PAD also mcreased with the number
of infections and was 3 0 (95% CI; 1.3-6.7) for one, 5.0
(95% CI; 0.1-11.9) for two and 7.6 (95% CI; 2.3-25 6)
for three positive titres However, among women with a
low CRP level, no significant mcreases of the odds ratios
were observed, 1.3 (95% CI; 0.5-3 0), 1.5 (95% CI; 0.6-
40) and 0.5 (95% CI; 0.1-4.8) for one, two or three
infections, respectively (Table 5).
4. Discussion
Our data indicate that women with evidence of
infection with C pneumoniae, H pylori or CMV have
an increased risk of PAD. Age is a confounding factor in
the relation between H. pylori infection and PAD, äs
well äs in the relation between CMV and PAD The
odds ratios slightly attenuate after adjustment for the
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Table 4











One* (n = 365)
17(1 1-25)
1 5 (10-23)
1 6 (1 0-2 5)
1 5 (1 0-2 4)
Twof (n = 222)
32(21-49)
2 7 (1 7-4 2)
29 (1 8-47)
27 (1 6-44)
Three* (n = 32)
4 5 (2 1 -9 8)
3 7 (1 7-8 1)
3 6 (1 6-8 4)
3 5 ( 1 5-8 1)
Infection with C pneumomae or H pylon or CMV
A combmation of two mfections (C pneumomae and H pylon or C pneumomae and CMV or H pylon and CMV)
A combmation of three mfections (C pneumomae, H pylon and CMV)
Tdble 5








































1 6 (0 6-4 3)
1 3 (0 5-3 0)
3 0 ( 1 3-67)
1 5 (0 6-4 0)
50 (2 1-11 9)
0 5 ( 0 1-48)
7 6 (2 3-25 6)
* Adjusted for age, smokmg, education, history of hypercholester-
olemia, of diabetes and of hypertension and body mass mdex
small age difference between the PAD patients and the
women controls. However, all three relations are
independent from the potentially confounding factors,
smoking and SES; after adjustment, the relations did
not alter significantly. Odds ratios adjusted for the
remaining vascular disease risk factors (viz. history of
hypercholesterolemia, diabetes mellitus or hypertension,
BMI and CRP concentration) are not shown in Table 3
because they were not considered äs potentially con-
founding factors. Of course, it could be possible that
mfections are associated with one of these risk factors.
Recently, it has been shown that current infections with
H. pylori and C. pneumoniae are associated with an
atherogenic lipid profile [16,17]. Still, in our opinion,
these risk factors should not be considered äs real
confounders, but rather äs 'intermediate variables' in
the relation between infection and atherosclerosis.
Nevertheless, if adjustment for all above mentioned
vascular disease risk factors was applied, the risks of
PAD associated with a C. pneumoniae infection or an
infection with CMV did not significantly change and
became 1.9 (95% CI; 1.2-3.1) and 1.6 (95% CI; 1.1-2.5),
respectively, whereas the risk related to H. pylori
infection did decrease significantly (1.3 (95% CI; 0.9-
2.0)).
Most (cross-sectional) case-control studies that have
recently been published did show positive relations
between IgG antibody titres against C. pneumoniae, H.
pylori or CMV and CAD [18-23]. In contrast, most
prospective studies did not show positive relations
between the IgG antibody titres to the three infectious
agents and CAD [24-33]. Studies that are cross-
sectional in nature, such äs the present investigation,
cannot establish causality but can only show associa-
tions. Prospective studies, on the other hand, have the
advantage of investigating temporal relationships, which
makes it possible to differentiate between cause and
effect. However, if the causal (exposure) variable varies
over time or if the variable has its causal effect within a
relatively short period of time (less than the follow-up
period), misclassification of the exposure variable might
occur to a larger extent in prospective studies compared
to cross-sectional studies. Therefore, the results from a
prospective study might be an underestimation of a real
causal relation. One might argue that the apparent
inconsistency of the results from prospective and cross-
sectional studies on the relation between infection and
CAD could be interpreted äs a lack of a causal role of
infections in atherogenesis. However, we argue that
because of the applied prospective designs, the results
that were found might be an underestimation of a real
causal relation. In view of this, it becomes clear that the
timing of the measurement of the antibody titres in
relation to the onset of clinically recognised CAD needs
to be carefully considered when interpreting the findings
from sero-epidemiologic studies [34].
Our results show that 23% of the PAD patients and
13% (85/632) of the controls had a high positive IgG
titre (> 1:6400) against C. pneumomae. The prevalence
of detectable IgG antibodies against C. pneumoniae was
much higher in both groups, 81 and 82% in patients and
controls, respectively. The high cut-off titre (1:6400) that
was used to calculate odds ratios has been defmed
prospectively and has frequently been used (in « 50% of
the publications) in other studies. If we had calculated
the odds ratio for PAD in women who are sero-positive
compared to women who are sero-negative, no signifi-
cant relation between C. pneumomae and PAD would
have been found. Only a high positive titre (> 1:6400) is
significantly associated with PAD. This might indicate
that the relation between C. pneumoniae and athero-
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sclerosis might be due to chronic or repeated infections
or might only be present in individuals with an enhanced
humoral immune response to antigen presentation.
Since the cases in our study were collected within the
10-year-period (1990-1999) before determination of the
antibody titres, it could be possible that cases were
infected after they were diagnosed with PAD. However,
no significant declining linear relations were found
between the year of diagnosis and the percentages of
the cases that were seropositive to each of the micro-
organisms (data not shown). This argues against the
possibility that PAD patients are more easily infected
then healthy controls and therefore it pleads for a causal
relation between infections and PAD.
The role of sero-epidemiology studies in determining
the relationship between infection and atherothrombotic
diseases, has been discussed in a recently published
report of The Workshop Group on Epidemiology' [35].
There is a concern that population subsets of particular
interest have not been dealt with in past epidemiology
studies; most studies have been carried out in middle-
aged and older male populations. Therefore, future
studies should be extended to additional populations,
such äs women and young adults. The selection of
young patients has the advantage that survival bias is
reduced. Moreover, since the prevalence of seropositiv-
ity in a population increases with age, the relation
between antibody titres and atherogenesis could be more
obvious in a young population because younger PAD
patients might contrast more strongly with age-matched
controls than older patients.
Recently, it has been shown that the dominant
mechanisms by which infections contribute to athero-
genesis, are sex-determined (in the cited study the
investigators have concentrated on CMV) [36].
In men, CMV was not independently associated with
CAD, but CMV was associated with the CRP level and
the CRP level was associated with CAD. In women,
however, CMV was independently associated with CAD
and did not significantly relate to the CRP level. The
authors of the cited article state that, in men, if CMV
contributes to CAD, it would appear to do so insofar äs
it predisposes to inflammation, whereas in women,
CMV is an independent risk factor for CAD. The
results of our study are in agreement with these earlier
findings with regard to the independent relations that
were found between CMV and the other pathogens and
atherosclerosis in women. However, although we also
did not find a significant association between the
different infections and the CRP level (data not shown),
we found that the relation between the infection bürden
and PAD is stronger in women with a high CRP level
compared to women with a low CRP level. This
indicates that, in women, äs in men, inflammation plays
a part in atherogenesis.
Of the 905 women controls who were approached to
participate in this study, 262 could not be reached or
refused to participate. Of the 270 PAD patients who
were successfully approached, 228 (78%) agreed to
participate and 43 could not be included. To test for
Potential selection bias in our study, we compared the
group of individuals who were included with those who
refused to participate. The distribution of vascular risk
factors, such äs hypertension, hypercholesterolemia,
diabetes and smoking, did not differ between the not
included and the included individuals.
According to our data, the risk of PAD seems not
only related to a single pathogen in particular, but also
to the cumulative number of pathogens to which an
individual has been exposed. Similar results were found
in (nested) case-control studies on the association
between the number of infections and CAD [37-41].
However, another, recently published, prospective study
indicated that infection bürden was not a risk factor for
future cardiovascular events [26]. It is noteworthy that
this prospective study also did not show a positive
relation between each separate infectious agent and
CAD. The role of pathogen bürden, together with
possible mechanisms that link infections with athero-
sclerosis, has been discussed earlier [42]. Beside the
proatherosclerotic effects of direct infection of cells of
the vessel wall, distant infections might also induce
changes in the vessel wall that contribute to atherogen-
esis. Firstly, these changes could be mediated through
alterations caused by circulating cytokines induced by
the infection of distant tissues. Secondly, molecular
mimicry—a mechanism requiring that the infecting
pathogen contains peptides homologous to those pre-
sent in host proteins—could result in an immune
response that, although it was stimulated by and
targeted to pathogen antigens, also attacks host tissues
that contain the cross-reacting peptides. This pathogen-
induced mechanism does not require the presence of a
pathogen in the target tissue and there are many possible
homologous pathogen/host peptides that could cause
the auto-immunity targeted to the arterial walls. Both
last mentioned mechanisms explain that a variety of
pathogens and that pathogen bürden are able to affect
the arterial wall in an indirect way.
In our data, we have found a positive relation between
the pathogen bürden and PAD, exclusively in the
subgroup of women with a high CRP level. This
suggests that an inflammatory response might indeed
be involved in the process that relates infections with
PAD. It appears that reactivity of the inflammatory
System is a necessary factor for chronic infections to
have a role in atherogenesis.
In summary, the present study demonstrates that
infections with C. pneumoniae, H. pylori and CMV are
related to PAD in approximately the same extent äs they
are related to CAD. Moreover, that the risk of PAD is
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not only related to a certam pathogen m particular, but
also to the cumulative number of mfections In our data,
we found that the positive relation between the patho-
gen bürden and PAD was found exclusively m the
subgroup of women with a high CRP level This
suggests that an mflammatory response might mdeed
be mvolved m the process that relates mfections with
PAD It appeais that reactivity of the mflammatoiy
System is a necessary factor for chromc mfections to
have a lole in atherogenesis
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